Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40771901	b-kml-qr	— (—)	168	1532	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Primary_lymphoid and hematopoietic malignant neoplasms

101

72.81

186.90

14.4

1.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

101

63.74

183.09

14.4

1.0

—

Other diseases of blood and blood-forming organs, wide

39.73

116.54

10.0

7.4

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

+∞

98.14

15.7

0.0

—

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

+∞

98.10

15.7

0.0

—

Myeloid leukaemia

+∞

97.67

15.3

0.0

—

Chronic myeloid leukaemia

+∞

65.81

16.6

0.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

9.43

65.40

9.4

8.8

—

Malignant neoplasm

10.89

53.33

12.9

1.1

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

10.65

49.17

12.8

1.2

—

Malignant neoplasm, wide definition for exclusion

10.65

49.17

12.8

1.2

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

10.65

49.17

12.8

1.2

—

Neoplasms

13.14

34.86

12.9

1.3

—

Any event in cancer register

6.94

32.02

12.4

4.8

—

Other and unspecified diseases of blood and blood-forming organs

+∞

24.07

8.2

0.0

—

Other diseases of blood and blood-forming organs

37.93

23.94

7.4

11.4

—

Lymphoid leukaemia

28.83

15.19

13.2

13.3

—

Bacterial infection, other or unspecified

4.80

14.88

11.6

9.0

—

Essential (haemorrhagic) thrombocythaemia

+∞

14.61

2.5

0.0

—

Any reimbursement code in KELA

8.02

12.59

15.6

1.3

—

Leukaemia of unspecified cell type

+∞

11.53

14.0

0.0

—

Leukaemia of unspecified cell type

+∞

11.53

14.0

0.0

—

Benign neoplasms

5.46

11.23

11.4

1.2

—

Other bacterial diseases

102

3.19

11.05

10.1

9.6

—

Gout, FINNGEN

5.12

10.77

12.7

8.8

—

Medical observation and evaluation for suspected diseases and conditions

3.90

8.99

9.5

8.3

—

Gout

4.46

8.95

12.7

7.7

—

Pain, not elsewhere classified

4.87

8.34

10.7

7.6

—

Heart failure, not strict

3.03

7.89

10.1

8.2

—

Abnormal findings on examination of blood, without diagnosis

3.53

7.85

10.3

9.7

—

Examination and observation for other reasons

3.77

7.51

8.3

—

Renal tubulo-interstitial diseases

110

2.72

7.33

10.0

8.6

—

Anaemias

7.98

7.31

9.3

1.6

—

Eosinophilia

+∞

7.30

1.0

0.0

—

COPD differential diagnosis

3.01

6.49

8.5

9.1

—

ILD differential diagnosis

3.01

6.49

8.5

9.1

—

2.62

6.35

9.7

8.2

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2.62

6.35

9.7

8.2

—

Fever of other and unknown origin

3.13

6.33

13.7

8.0

—

Covid-19 confirmed case

4.21

6.27

7.0

8.9

—

Other abnormal findings of blood chemistry

18.09

6.26

5.3

16.4

—

Chronic myeloproliferative disease

+∞

6.26

6.8

0.0

—

Excluding asthma or asthma-COPD overlap

2.90

6.15

8.5

8.8

—

Pneumonias (Asthma/COPD co-morbidities)

114

2.43

5.96

10.4

8.9

—

Heart failure and antihypertensive medication

5.14

5.93

10.9

6.8

—

Tramadol

2.63

5.82

11.5

8.7

—

Other pulmonary diagnosis

2.81

5.69

8.8

—

All pneumoniae

117

2.36

5.61

10.4

9.0

—

Codes for special purposes

3.18

5.57

6.8

10.2

—

Provisional assignment of new diseases of uncertain etiology

3.18

5.57

6.8

10.2

—

Implicit viral Sepsis

5.24

5.52

15.2

8.9

—

Diarrhoea and gastroenteritis of presumed infectious origin

100

2.64

5.43

11.3

8.1

—

Dentinal caries

4.10

5.31

14.9

7.9

—

Viral Sepsis

5.01

5.25

15.2

8.5

—

Use of hypnotics and sedatives

115

2.21

5.14

11.2

8.5

—

Certain infectious and parasitic diseases

2.38

5.13

12.4

7.3

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

3.90

5.09

8.9

1.0

—

Infections, IBD-co-morbidities

5.35

5.03

14.6

7.9

—

Benign neoplasm of colon, rectum, anus and anal canal

3.97

4.95

12.9

1.0

—

Influenza and pneumonia

118

2.23

4.93

9.7

8.7

—

Dental caries

3.85

4.90

14.9

7.8

—

Other soft tissue disorders, not elsewhere classified

103

2.28

4.85

11.8

8.2

—

Acute bronchitis

3.10

4.85

12.1

8.9

—

Aplastic and other anaemias

2.93

4.83

10.3

8.1

—

Other and unspecified anaemias

2.98

4.76

10.8

7.8

—

Other anaemias

2.97

4.73

10.8

7.8

—

Codeine

2.31

4.72

10.2

8.6

—

General symptoms and signs

2.19

4.65

11.6

8.0

—

Heart failure,strict

2.89

4.62

10.1

8.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

2.89

4.54

11.8

8.3

—

Asthma, excluding more controls

2.78

4.50

6.4

9.0

—

Asthma (only as main-diagnosis), excluding more controls

2.85

4.49

6.0

9.0

—

COPD/asthma related infections

2.20

4.48

9.7

8.2

—

COPD/asthma/ILD related infections

2.20

4.48

9.8

8.2

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

119

2.18

4.45

10.8

8.9

—

Other septicaemia

3.27

4.45

9.9

8.6

—

Diseases of oesophagus, stomach and duodenum

118

2.11

4.39

11.1

8.7

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

3.84

4.39

10.0

1.0

—

Pneumonia, organism unspecified

110

2.24

4.35

11.1

9.3

—

Asthma (mode)

2.60

4.21

6.2

9.1

—

Polyarthropathies

2.39

4.21

11.2

7.8

—

Renal failure

2.77

4.17

9.8

8.7

—

Any gastric operation

2.47

4.15

11.6

7.5

—

GASTRO-related operations

2.47

4.15

11.6

7.5

—

Statin medication

2.45

4.11

9.9

8.2

—

Other heart diseases

2.87

4.09

11.5

8.2

—

Septicaemia

2.97

4.05

9.4

9.1

—

Asthma

2.54

4.02

6.2

9.1

—

Persons encountering health services for examination and investigation

2.75

4.01

7.7

8.3

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

104

2.40

4.00

9.8

8.7

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

4.00

3.97

11.0

6.6

—

Bronchitis

125

2.05

3.97

12.2

7.9

—

106

2.04

3.93

10.4

8.2

—

All-cause Heart Failure

2.55

3.90

10.3

8.1

—

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

9.43

3.86

2.0

1.0

—

Complications of medical and surgical care

119

2.23

3.82

9.7

8.7

—

Acute tubulo-interstitial nephritis

2.46

3.81

8.8

8.2

—

Opioids

2.12

3.81

11.6

8.7

—

Heart failure, strict

2.51

3.79

10.3

8.2

—

Codeine or tramadol medication

118

1.97

3.74

9.1

9.0

—

Intestinal infectious diseases

128

2.07

3.71

12.5

8.2

—

Visual disturbances

2.57

3.70

10.1

8.8

—

Bacterial pneumonia, not elsewhere classified

2.84

3.70

11.5

9.3

—

Asthma (only as main-diagnosis)

2.52

3.66

6.0

9.1

—

Nerve, nerve root and plexus disorders

124

1.98

3.61

9.4

9.2

—

Diseases of the respiratory system

2.51

3.57

10.0

7.8

—

Benign neoplasms

2.03

3.49

11.1

8.1

—

Bacterial pneumoniae

2.74

3.48

11.5

9.7

—

Cardiovascular diseases (excluding rheumatic etc)

2.46

3.46

13.4

8.0

—

Non-ischemic cardiomyopathy

3.23

3.42

12.2

6.3

—

ILD medications: prednisolone, methylprednisolone, prednisone

113

1.95

3.41

8.1

9.7

—

Superficial injury of hip and thigh

5.00

3.36

10.1

10.9

—

Insulin medication

2.31

3.36

10.0

10.3

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

3.90

3.34

6.5

1.0

—

Visual disturbances and blindness

2.41

3.29

10.1

9.1

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

8.58

3.26

7.8

1.0

—

Finngen Rheumatological endpoints

105

1.95

3.20

9.4

9.1

—

Acute renal failure

3.57

3.19

7.8

9.8

—

Pain in limb

101

2.08

3.19

14.0

7.9

—

Chronic periapical parodontitis

3.34

3.19

15.4

7.8

—

Poisoning by drugs, medicaments and biological substances

3.34

3.19

7.9

10.1

—

Asthma, unspecified (mode), excluding more controls

2.73

3.18

7.4

9.1

—

Other reaction to severe stress, and adjustment disorders

2.86

3.18

14.5

8.6

—

Unspecified kidney failure

6.37

3.18

9.0

12.9

—

Benign neoplasm of ovary

6.37

3.18

6.9

1.0

—

Other diseases of anus and rectum

2.86

3.18

10.6

8.7

—

Chronic lower respiratory diseases

123

1.85

3.14

7.0

10.1

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

3.31

3.12

8.4

1.0

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

3.30

3.11

8.4

1.0

—

Chronic gastritis

3.08

8.8

8.1

—

Cardiovascular diseases

2.43

3.07

13.5

7.6

—

Glucagon-like peptide-1 (GLP-1) analogues

2.26

3.06

9.4

9.0

—

Injuries to the hip and thigh

2.46

3.05

10.8

8.8

—

Chronic periodontitis, including avohilmo

121

1.96

3.04

9.0

9.2

—

Insulin, combination of fast acting with intermediate-acting or long-acting

2.19

3.02

10.0

10.1

—

Benign neoplasm: Rectum, anus and anal canal

5.84

3.02

10.9

1.0

—

Parodontitis

121

1.95

3.01

9.0

9.2

—

Parodontitis or operation codes

121

1.95

3.00

9.0

9.2

—

Biomechanical lesions, not elsewhere classified

10.02

2.98

11.6

13.6

—

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

10.01

2.98

9.6

1.0

—

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

10.01

2.98

9.6

1.0

—

Benign neoplasm of other and unspecified endocrine glands

10.01

2.98

7.2

1.0

—

Other acute lower respiratory infections

2.30

2.97

11.6

10.2

—

Other heart diseases, wide

101

1.97

2.97

11.4

8.9

—

Myocardial infarction, without ST-elevation

2.49

2.96

8.9

9.1

—

Explicit Sepsis

2.47

2.94

9.4

8.2

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

5.84

2.93

2.0

1.0

—

Benign lipomatous neoplasm

4.71

2.91

8.3

1.0

—

Spondylosis

2.19

2.89

8.0

8.6

—

Implicit bacterial Sepsis

2.53

2.88

11.9

8.1

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.39

2.87

14.6

13.1

—

Viral pneumonia

5.39

2.87

8.3

11.2

—

Anxiety disorders, excluding more controls

2.02

2.84

11.5

8.5

—

Chronic kidney disease

2.91

2.83

12.6

9.5

—

Oedema, not elsewhere classified

2.91

2.82

9.0

7.5

—

Complications of surgical and medical care, not elsewhere classified

126

1.88

2.79

9.8

8.9

—

Bacterial Sepsis

2.36

2.79

11.6

8.2

—

Parodontitis and operation codes

121

1.93

2.78

8.8

9.3

—

Inflammatory bowel disease treatment related agents

123

1.80

2.77

9.1

9.4

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.92

2.77

8.2

11.7

—

Poisoning by medicine

3.23

2.77

8.6

10.3

—

Hypothyroidism, drug reimbursement

5.56

2.76

7.4

1.7

—

Lesion of lateral popliteal nerve

8.35

2.75

13.0

11.5

—

Malignant neoplasm of thyroid gland

8.35

2.75

9.6

15.3

—

Malignant neoplasm of endocrine gland

8.35

2.75

9.6

15.3

—

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

8.32

2.74

6.2

1.0

—

Other and unspecified visual disturbances

5.01

2.72

7.0

12.9

—

Bacterial pneumonia (organism specified)

2.38

2.72

11.5

9.1

—

Benign neoplasm: Rectum

6.00

2.69

10.2

1.0

—

Atrial fibrillation and flutter

3.01

2.69

9.8

7.7

—

Spondylopathies

1.90

2.64

8.7

9.0

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.12

2.63

9.7

8.5

—

Localized swelling, mass and lump of skin and subcutaneous tissue

2.65

2.62

9.9

8.3

—

Symptoms and signs involving the skin and subcutaneous tissue

119

2.01

2.61

9.6

9.0

—

Diseases of liver

2.55

2.61

8.9

9.2

—

Benign neoplasm: Colon

3.19

2.56

12.0

1.0

—

Coxarthrosis [arthrosis of hip](FG)

2.14

2.53

6.9

8.2

—

Specific personality disorders

3.03

2.52

7.9

11.2

—

Personality disorders, excluding more controls

3.03

2.52

7.9

10.1

—

Asthma, unspecified (mode)

2.39

2.52

7.4

9.2

—

Persons encountering health services for specific procedures and health care

126

1.77

2.49

10.9

8.8

—

Acute upper respiratory infections of multiple and unspecified sites

1.97

2.48

13.6

8.9

—

Insulin, intermediate and long-acting

2.11

2.48

10.3

9.8

—

Other pleural conditions

4.38

2.47

12.6

9.1

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

4.38

2.47

6.6

12.3

—

Other inflammation of eyelid

4.38

2.47

5.6

11.3

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

4.52

2.46

2.0

1.0

—

Acute pharyngitis

4.35

2.45

5.0

12.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.42

2.44

14.1

7.2

—

ILD medications: immunosuppressive drugs

2.06

2.43

8.5

10.1

—

All influenza

2.94

2.41

11.9

11.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2.94

2.41

7.5

8.0

—

Acute upper respiratory infections

120

1.77

2.40

11.1

8.2

—

Benign neoplasm: Colon, unspecified

4.98

2.39

3.3

1.0

—

Hypertension, essential

1.93

2.37

8.1

9.6

—

Agranulocytosis

6.25

2.37

10.6

11.4

—

Transplanted organ and tissue status

4.12

2.36

13.3

11.5

—

Oral corticosteroids

121

1.75

2.34

8.4

9.4

—

General examination and investigation of persons without complaint and reported diagnosis

2.28

2.34

10.7

8.3

—

Atrial fibrillation and flutter with reimbursement

3.05

2.28

7.6

6.6

—

Fall on and from stairs and steps

2.68

2.27

9.1

8.5

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

4.62

2.27

3.5

1.0

—

Chronic periodontitis

3.48

2.26

10.6

7.0

—

Iron deficiency anaemia

2.29

2.26

8.0

8.9

—

Coxarthrosis, primary

2.00

2.25

6.9

8.8

—

Other metabolic disorders

3.89

2.25

6.6

11.1

—

Melanocytic naevi

3.89

2.25

4.3

1.3

—

ILD medications

115

1.72

2.23

7.8

9.5

—

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

5.14

2.23

11.2

1.0

—

Nutritional anaemias

2.15

2.22

8.4

8.8

—

Other specified and unspecified personality disorders

5.56

2.21

8.0

12.7

—

Hypertensive diseases

1.86

2.18

6.7

9.6

—

Hypertension

1.86

2.18

6.7

9.6

—

Cerebrovascular diseases (FINNGEN)

2.71

2.15

10.6

6.3

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

3.35

2.15

2.9

1.0

—

Psychiatric diseases

106

1.70

2.12

11.3

8.7

—

Malaise and fatigue

2.19

2.12

8.6

7.5

—

Arthropathies

1.77

2.11

11.9

7.8

—

Diseases of the eye and adnexa

1.85

2.09

12.6

8.2

—

Early onset COPD, excluding more controls

3.20

2.09

10.3

9.8

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

4.58

2.07

11.2

1.0

—

Erysipelas

2.15

2.07

6.7

9.5

—

Spinal stenosis

1.98

2.07

9.5

8.5

—

Benign leiomyoma with endometriosis

5.00

2.07

11.0

1.0

—

Any mental disorder

107

1.68

2.06

11.5

8.6

—

Metabolic disorders

111

1.73

2.06

10.1

9.7

—

Parodontitis or/and operation codes

1.98

2.05

11.1

8.9

—

Diseases of pulp and periapical tissues

2.32

2.04

15.7

8.9

—

Chronic periodontitis, complicated

4.00

2.04

12.2

11.7

—

Diseases of arteries, arterioles and capillaries

1.91

2.03

10.5

8.7

—

Heart failure and coronary heart disease

2.49

2.03

8.8

8.4

—

Coxarthrosis, primary, with hip surgery

2.07

2.03

7.2

8.6

—

Soft tissue disorders

104

1.70

2.03

11.2

8.2

—

Endocrine, nutritional and metabolic diseases

1.80

2.02

8.8

9.6

—

Neurotic, stress-related and somatoform disorders

113

1.76

2.02

11.5

8.7

—

Suicide or other Intentional self-harm

2.63

2.00

7.5

8.6

—

Personality disorders

2.63

2.00

7.9

11.3

—

Coxarthrosis

2.01

1.99

7.5

7.3

—

Cough

2.15

1.97

6.2

8.5

—

Parasetamol

1.79

1.97

10.7

10.1

—

Hypothyroidism, levothyroxine purchases

3.66

1.96

7.0

1.5

—

Hypothyroidism and >3 levothyroxin purchases

3.66

1.96

7.0

1.5

—

Hypothyroidism (congenital or acquired)

3.66

1.96

7.0

1.5

—

Disorders of vitreous body

2.03

1.95

7.6

8.4

—

Anxiety disorders

114

1.74

1.95

11.5

8.6

—

Other disorders of nervous system

4.55

1.94

17.4

11.8

—

Pneumonitis due to solids and liquids

4.55

1.94

6.4

8.9

—

Conductive hearing loss, unspecified

4.55

1.94

6.2

16.5

—

Benign neoplasm of other and ill-defined parts of digestive system

4.55

1.94

16.4

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

121

1.67

1.93

9.4

9.5

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

112

1.69

1.90

9.5

9.3

—

Diabetes, varying definitions

114

1.68

1.90

9.0

9.3

—

Diabetes mellitus

114

1.68

1.89

9.0

9.3

—

Oxycodone

2.32

1.88

10.6

8.2

—

Benign neoplasm of ovary

3.18

1.88

6.9

9.4

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

125

1.68

1.86

8.3

9.6

—

Atherosclerosis, excluding cerebral and coronary sclerosis

2.06

1.85

11.8

8.1

—

Cardiac arrhythmias

1.92

1.84

9.6

8.8

—

Type 2 diabetes, definitions combined, including avohilmo

105

1.69

1.84

7.3

9.0

—

Continuous positive airway pressure

2.88

1.84

18.8

8.4

—

Allergic asthma (mode), excluding more controls

3.12

1.84

3.6

9.3

—

Other diseases of intestine

3.53

1.83

6.0

8.4

—

Hernia of abdominal wall, postoperative

3.53

1.83

2.8

6.6

—

Lower back pain or/and sciatica

135

1.64

1.83

9.4

9.0

—

Asthma-related pneumonia

2.20

1.83

5.2

9.1

—

Asthma-related pneumonia or sepsis

2.20

1.83

5.2

9.1

—

Asthma, hospital admissions 3, pneumonia

2.20

1.83

5.2

9.1

—

Disorders of vitreous body and globe

1.97

1.83

7.6

8.4

—

Dizziness and giddiness

104

1.80

1.82

7.6

9.6

—

Fibrosis and cirrhosis of liver

4.17

1.82

4.4

10.9

—

Overexertion and strenuous or repetitive movements

4.17

1.82

14.6

16.2

—

Complications of procedures, not elsewhere classified

124

1.74

1.82

10.0

9.0

—

Autoimmune diseases related-to ILD

133

1.72

1.82

7.8

9.6

—

Otitis media, unspecified

4.19

1.81

6.2

12.0

—

Cystitis

100

1.71

1.80

10.4

7.6

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

2.57

1.80

11.1

7.0

—

Hyperplasia of prostate

2.14

1.77

8.3

10.6

—

Other diseases of pleura

2.00

1.75

8.8

8.9

—

Viral infections characterized by skin and mucous membrane lesions

2.09

1.75

11.6

9.1

—

3.34

1.74

6.7

12.0

—

Pain in joint

1.91

1.74

10.9

8.1

—

COPD

2.00

1.74

8.9

9.7

—

Other diseases of hard tissues of teeth

1.89

1.74

9.9

8.6

—

Heart failure and bmi 25plus

2.30

1.73

7.0

9.2

—

Exposure to other specified factors

117

1.76

1.70

12.9

9.4

—

Fall on same level involving ice and snow

1.88

1.70

11.5

9.5

—

Other and unspecified iron deficiency

2.29

1.70

10.5

8.5

—

Other benign neoplasms of skin

2.86

1.68

11.7

1.0

—

Disorders of adult personality and behaviour

2.38

1.67

7.9

11.9

—

Implicit Sepsis

1.76

1.66

11.3

8.6

—

Lung cancer and mesothelioma

2.85

1.65

2.0

8.8

—

Persistent mood disorders

2.80

1.65

5.9

9.8

—

Biguanides

109

1.64

1.63

7.3

9.3

—

Diabetes medication

117

1.61

1.63

8.5

9.4

—

L04AD Calcineurin inhibitors

3.57

1.61

12.2

12.6

—

Cerebral palsy and other paralytic syndromes

3.57

1.61

14.6

13.4

—

Allergic asthma (mode)

2.75

1.61

3.6

10.0

—

Chronic sinusitis

1.95

1.58

8.9

9.8

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

122

1.62

1.58

11.4

8.5

—

Other condition

3.00

1.58

14.7

11.2

—

Rheumatism, unspecified

3.00

1.58

2.0

8.9

—

Lung diseases due to external agents

3.00

1.58

5.5

10.3

—

Antihypertensive medication - note that there are other indications

1.94

1.57

15.5

8.9

—

Depression medications

2.94

1.56

13.0

1.5

—

Coronary angioplasty

2.08

1.55

12.5

8.4

—

Gingivitis and periodontal diseases

1.66

1.54

11.3

8.4

—

Acute sinusitis

1.89

1.54

9.2

8.8

—

Asthma, including avohilmo

132

1.54

1.53

5.8

10.1

—

Gastro-oesophageal reflux disease

101

1.75

1.53

12.5

8.4

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2.27

1.53

7.5

9.6

—

Diseases of middle ear and mastoid

1.82

1.52

6.4

10.6

—

Valvular heart disease excluding rheumatic fever

2.01

1.51

12.2

8.4

—

Non-rheumatic valve diseases

2.00

1.51

12.2

8.4

—

Hypertensive diseases (excluding secondary)

1.94

1.51

7.9

7.6

—

Nonorganic sleeping disorders, excluding more controls

2.86

1.50

9.8

8.3

—

Suppurative and unspecified otitis media

2.09

1.48

6.7

11.6

—

Pain in throat and chest

1.64

1.48

12.8

10.0

—

Pain (limb, back, neck, head abdominally)

1.69

1.47

10.0

8.2

—

Diseases of male genital organs

1.86

1.47

8.7

11.7

—

Other (not insulin) diabetes medications

110

1.59

1.47

7.3

9.1

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

3.35

1.46

5.8

7.9

—

Myocardial infarction, strict

1.92

1.45

10.8

8.7

—

Other diseases of intestines

120

1.55

1.45

9.5

9.0

—

Other viral diseases

2.22

1.45

11.5

10.8

—

Pleural effusion

2.50

1.45

9.1

9.7

—

Pure hypercholesterolaemia

1.70

1.44

10.8

9.7

—

Other chronic obstructive pulmonary disease, including avohilmo

1.78

1.44

8.1

9.2

—

Obesity, other/unspecified

2.12

1.44

5.7

9.6

—

Unspecified privation

3.13

1.44

7.8

12.4

—

Gastric ulcer

2.73

1.43

12.3

7.8

—

Myocardial infarction

1.85

1.41

10.8

8.8

—

Excessive attrition of teeth

2.21

1.40

8.2

7.3

—

Subjective visual disturbances

2.25

1.40

9.4

8.6

—

Hard cardiovascular diseases

1.66

1.39

10.3

8.4

—

Superficial injury of head

2.41

1.39

10.6

8.5

—

Other specific joint derangements/joint disorders

1.70

1.39

11.3

7.7

—

COPD (mode)

2.23

1.37

6.9

9.4

—

Dysplasia of cervi uteri

0.00

1.37

0.0

7.4

—

Other and unspecified effects of external causes

2.20

1.36

14.7

8.3

—

Other disorders of the musculoskeletal system and connective tissue

2.61

1.36

10.8

10.7

—

Zoster [herpes zoster]

2.61

1.36

9.5

7.8

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

2.27

1.36

12.4

9.0

—

Bell's palsy

2.94

1.36

10.8

10.6

—

Iron deficiency anaemia secondary to blood loss (chronic)

2.94

1.36

3.6

10.3

—

Type 2 diabetes

111

1.55

1.34

7.2

9.2

—

Neurological diseases, wide definition

2.26

1.34

16.6

7.8

—

Type 2 diabetes, strict (exclude DM1)

107

1.56

1.34

7.4

8.9

—

Abnormal findings on diagnostic imaging of lung

1.83

1.34

10.3

8.5

—

Type 2 diabetes, definitions combined

107

1.56

1.34

7.4

8.9

—

Other specified/unspecified arthritis

2.14

1.33

7.3

7.1

—

Mycoses

2.14

1.33

15.4

8.6

—

First line medication for Crohn's disease

115

1.52

1.33

9.0

9.3

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

2.18

1.32

12.1

1.0

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

2.18

1.32

12.1

1.0

—

All dysplastic lesions of the cervix uteri, vagina or vulva

0.00

1.32

0.0

8.3

—

Abdominal and pelvic pain

106

1.52

1.31

14.0

8.3

—

Budesonide

2.50

1.30

11.8

9.9

—

Adjustment and management of implanted device

2.50

1.30

12.7

8.8

—

Other disorders of teeth and supporting structures

2.35

1.29

10.1

7.4

—

Other disorders of kidney and ureter

2.78

1.28

6.4

11.9

—

Generalized anxiety disorder

2.78

1.28

12.2

11.9

—

Follow-up examination after treatment for conditions other than malignant neoplasms

2.06

1.26

12.2

7.7

—

Coronary artery bypass grafting

2.11

1.25

10.1

8.5

—

Autoimmune diseases excluding thyroid diseases

119

1.49

1.25

9.9

9.1

—

Substance abuse, excluding more controls

1.75

1.24

9.0

9.5

—

Other diseases of lip and oral mucosa

2.40

1.24

13.5

7.5

—

Leiomyoma of uterus

2.17

1.24

10.3

1.2

—

Nontoxic goitre/thyroid nodule

2.00

1.23

9.9

8.9

—

Paroxysmal tachycardia

2.42

1.23

11.3

5.9

—

Other chronic obstructive pulmonary disease

1.82

1.22

8.8

9.5

—

Other and unspecified disorders of vitreous body

1.85

1.21

4.7

8.7

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

2.04

1.21

13.6

8.8

—

Gastroduodenal ulcer

2.16

1.21

9.5

8.3

—

STROKE

1.71

1.18

11.2

7.3

—

Exclusions for E4_PCOS_BROAD

2.31

1.18

3.7

10.2

—

Fracture of femur

2.09

1.16

9.1

9.3

—

Thyrotoxicosis, other and/or unspecified

0.00

1.16

0.0

8.8

—

Condition for Implicit Sepsis (Organ dysfunction codes)

113

1.54

1.16

11.8

9.2

—

Dermatophytosis

2.50

1.15

15.0

10.8

—

Other embolism and thrombosis

2.50

1.15

11.2

8.7

—

Purpura and other haemorrhagic conditions

2.50

1.15

6.6

9.8

—

Burns and corrosions

2.50

1.15

16.8

10.5

—

All influenza (not pneumonia)

2.50

1.15

10.2

13.4

—

Diagnoses used for exclusion with ILD

2.05

1.15

4.4

9.7

—

All dysplastic lesions of the cervix uteri

0.00

1.15

0.0

8.8

—

Strabismus

2.05

1.15

8.5

8.8

—

Emergency coronary revascularization (for ACS)

1.72

1.14

12.1

9.1

—

Stroke, excluding SAH

1.65

1.13

10.1

8.5

—

Disorders of lipoprotein metabolism and other lipidaemias

1.54

1.12

9.2

9.4

—

Asthma (diagnoses ohter than nonallergic)

135

1.52

1.12

6.0

9.4

—

Asthma-related infections

1.67

1.11

6.0

10.5

—

Asthma, hospital admission 2, infections

1.67

1.11

6.0

10.5

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

2.27

1.10

11.9

1.0

—

Non-small cell lung cancer

2.26

1.10

2.0

9.7

—

Other and unspecified polyneuropathies, also in other diseases

2.26

1.10

13.7

9.1

—

Benign neoplasm: Rectum, anus and anal canal

2.26

1.10

10.9

9.3

—

Type 2 diabetes, wide definition

1.56

1.09

9.0

8.9

—

Benign leiomyoma with endometriosis

2.38

1.09

11.0

9.5

—

Insulin, fast-acting (human)

2.38

1.09

16.2

11.2

—

Candidiasis

2.38

1.09

17.6

10.4

—

Diseases of oral cavity, salivary glands and jaws

1.53

1.09

10.5

8.4

—

Ulcer of lower limb, not elsewhere classified

2.38

1.09

10.0

9.0

—

Used for control exclusion in common control thyroid runs

108

1.46

1.08

10.0

9.2

—

Early onset COPD

1.95

1.08

10.3

9.5

—

Headache

1.67

1.08

10.7

7.5

—

Insulin, fast-acting

1.86

1.07

9.5

9.7

—

Other dorsopathies, not elsewhere classified

109

1.45

1.05

8.9

9.3

—

Major coronary heart disease event excluding revascularizations

1.61

1.04

10.0

8.8

—

Asthma, hospital admissions , main diagnosis only

137

1.50

1.04

6.0

9.5

—

Chronic pancreatitis

2.27

1.03

9.0

10.7

—

Benign neoplasm of other and unspecified endocrine glands

2.27

1.03

7.2

11.0

—

Other disorders of eye and adnexa

2.27

1.03

15.8

11.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

105

1.59

1.03

10.3

8.4

—

Mood disorders, excluding more controls

102

1.49

1.03

9.8

8.7

—

Dental pulpitis 1

108

1.44

1.02

11.2

8.9

—

Diseases of pulp and periapical tissues, including avohilmo

108

1.44

1.02

11.2

8.9

—

Dental pulpitis 4

108

1.44

1.02

11.2

8.9

—

Combinations of oral blood glucose lowering drugs

1.92

1.02

7.0

9.7

—

Other arthritis (FG)

1.92

1.02

7.3

7.7

—

Other medical care

1.78

1.01

4.3

8.3

—

Gout, unspecified

2.00

1.00

12.1

9.4

—

Polyneuropathies and other disorders of the peripheral nervous system

2.00

1.00

13.7

8.2

—

Sleep disorders

2.00

1.00

8.6

9.8

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

1.87

0.99

9.0

9.7

—

Other skin changes

2.17

0.98

5.6

9.5

—

Migraine with aura and triptan purchases

2.17

0.98

9.6

12.7

—

Other bacterial intestinal infections

2.17

0.98

15.4

7.0

—

Obstructed labour due to malposition and malpresentation of fetus

0.00

0.98

0.0

7.9

—

Migraine with aura

1.94

0.97

9.7

9.2

—

Persons encountering health services in circumstances related to reproduction

0.50

0.96

13.8

9.9

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.70

0.96

10.5

9.2

—

Nausea and vomiting

1.91

0.95

9.4

6.5

—

Symptoms and signs involving the digestive system and abdomen

106

1.42

0.94

13.3

8.3

—

Diseases of the ear and mastoid process

120

1.39

0.94

6.4

9.9

—

Other neurological diseases

106

1.52

0.94

12.0

8.3

—

Psoriasis vulgaris

1.89

0.94

5.9

8.7

—

Ischaemic heart disease, wide definition

1.51

0.93

12.5

8.0

—

Low back pain

108

1.50

0.93

10.4

9.2

—

Exposure to unspecified factor

141

1.43

0.93

10.8

8.8

—

Benign neoplasm of colon, rectum, anus and anal canal

1.57

0.93

11.5

8.5

—

Abnormal serum enzyme levels

1.74

0.93

7.4

10.5

—

Substance use, excluding alcohol

2.14

0.91

13.7

10.3

—

Autoimmune diseases excluding thyroid diseases, strict definition

115

1.41

0.90

10.2

9.3

—

Benign neoplasm: Rectum

2.07

0.89

10.2

9.8

—

DVT of lower extremities

2.07

0.89

18.2

7.2

—

Coagulation defects, purpura and other haemorrhagic conditions

2.07

0.89

5.7

9.5

—

Coronary revascularization (ANGIO or CABG)

1.68

0.88

10.6

8.5

—

Stroke, including SAH

1.53

0.88

10.1

8.4

—

COPD, early/later onset

1.62

0.87

8.8

9.3

—

Gout, strict definition

2.00

0.87

13.0

8.0

—

Other diseases of liver

2.00

0.87

8.0

8.7

—

Coronary atherosclerosis

1.51

0.86

12.7

8.1

—

Major coronary heart disease event

1.51

0.86

10.6

8.2

—

Type of accident

1.82

0.85

13.9

8.8

—

COPD related to multimorbidity

1.68

0.85

9.6

9.0

—

Schizophrenia or delusion, excluding more controls

1.80

0.85

3.5

9.6

—

Triptan medication for migraine, single purchase ok

114

0.59

0.84

9.5

9.6

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

114

0.59

0.84

9.5

9.6

—

Sleep apnoea

139

0.63

0.84

7.4

9.5

—

Benzodiazepine use

138

1.39

0.84

7.6

9.6

—

Salpingitis and oophoritis

1.94

0.84

4.0

8.9

—

Adverse effects, not elsewhere classified

1.94

0.84

15.2

10.0

—

Nonorganic sleeping disorders

1.94

0.84

9.8

10.6

—

Depression or dysthymia

1.49

0.84

13.1

9.1

—

Conductive and sensorineural hearing loss

111

1.43

0.84

7.6

8.8

—

Peripheral artery disease

1.63

0.83

13.2

8.1

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.75

0.83

4.4

8.6

—

Other disorders of ear

118

1.41

0.83

8.0

9.3

—

Dorsalgia

109

1.39

0.83

10.7

9.3

—

Effects of foreign body entering through natural orifice

1.74

0.82

7.1

10.6

—

Dislocation, sprain and strain of joints and ligaments of knee

1.53

0.82

11.8

10.1

—

Car occupant injured in other and unspecified transport accidents

1.88

0.81

13.2

10.3

—

Acute pancreatitis

1.88

0.81

14.3

9.0

—

Dental pulpitis 2, only avohilmo

1.48

0.81

9.7

9.0

—

Other antidepressants

110

1.38

0.81

11.9

8.7

—

Anxiety (asthma-related co-morbidities)

1.56

0.80

14.1

9.2

—

Irregular menses

1.65

0.80

8.6

8.4

—

COPD, hospital admission 2, with asthma infections

1.74

0.80

8.2

9.7

—

Ischaemic Stroke, excluding all haemorrhages

1.53

0.80

10.8

8.1

—

Spondylolisthesis/Spondylolysis

1.82

0.79

10.3

8.6

—

Phlebitis and thrombophlebitis (not including DVT)

1.82

0.79

12.8

7.2

—

Acute pancreatitis (for exclusion)

1.82

0.79

14.3

8.7

—

Substance abuse

101

1.51

0.79

9.0

10.9

—

HSIL lesion of the cervix uteri, vagina or vulva

0.00

0.78

0.0

9.6

—

Insulin, fast-acting or short human

1.67

0.78

9.5

10.0

—

Postmenopausal bleeding

1.77

0.78

10.6

5.4

—

All anxiety disorders

1.52

0.77

13.3

9.2

—

Chondropathies

0.00

0.77

0.0

11.2

—

Other gastritis (incl. Duodenitis)

1.77

0.76

9.5

7.6

—

Dorsopathies

109

1.36

0.76

9.8

9.3

—

Venous thromboembolism

1.54

0.75

11.9

8.4

—

Ischemic heart diseases

1.43

0.75

12.5

8.3

—

Psoriasis

1.70

0.75

6.9

8.7

—

Disturbances of skin sensation

1.84

0.73

11.1

10.1

—

Dental operations

1.45

0.73

11.5

9.6

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.63

0.73

11.0

9.6

—

Genitourinary diseases

1.48

0.73

11.9

8.8

—

L04AX Other immunosuppressants

100

1.50

0.72

5.9

10.1

—

Mental and behavioural disorders due to psychoactive substance use

102

1.48

0.72

9.0

11.0

—

L04AA Selective immunosuppressants

1.80

0.72

11.6

8.1

—

Autoimmune diseases

119

1.33

0.72

10.6

9.1

—

Glucosamine medication

1.53

0.71

9.4

8.2

—

Dental pulpitis 1, only avohilmo

113

1.34

0.71

10.9

9.2

—

Dental pulpitis 4, only avohilmo

113

1.34

0.71

10.9

9.2

—

Functional dyspepsia

1.75

0.71

12.9

8.1

—

Other joint disorders

1.39

0.70

12.1

7.7

—

Chronic laryngitis and laryngotracheitis

1.92

0.70

7.6

8.2

—

Abnormalities of heart beat

1.56

0.70

6.7

9.4

—

Obesity

100

1.49

0.70

6.1

9.6

—

Fissure and fistula of anal and rectal regions

1.71

0.69

16.4

8.5

—

Obesity and other hyperalimentation

100

1.48

0.69

6.1

9.7

—

Disorders of eyelid, lacrimal system and orbit

125

1.38

0.69

9.5

8.7

—

Recurrent or chronic depression

1.62

0.69

11.6

9.2

—

Somatoform disorder

1.85

0.68

9.6

8.3

—

Bacterial intestinal infections, IBD co-morbidities

1.85

0.68

15.4

8.5

—

Second line medication for Crohn's disease

102

1.47

0.67

5.9

10.0

—

Gout, idiopatic and unspecified

1.63

0.66

12.1

9.5

—

Dermatitis and eczema

139

1.32

0.66

8.2

9.3

—

Other respiratory diseases principally affecting the interstitium

1.79

0.66

5.8

9.7

—

Abnormalities of breathing

100

1.37

0.66

7.0

9.7

—

Melanocytic naevi

1.59

0.65

4.3

9.3

—

Deviated nasal septum

1.61

0.64

12.1

9.4

—

Artificial joint operation, meniscal resection

127

0.68

0.64

9.7

8.8

—

Sleep apnoea, including avohilmo

139

0.70

0.64

8.1

9.3

—

Benign neoplasm of other and ill-defined parts of digestive system

1.72

0.64

16.4

8.7

—

Insomnia

1.72

0.64

6.4

11.2

—

Sequelae with surgical and medical care as external cause

1.72

0.64

10.2

9.1

—

Other and unspecified nonorganic psychotic disorders

1.72

0.64

3.4

12.6

—

Other or unspecified ileus, impaction or obstruction

1.72

0.64

12.8

8.2

—

Dental pulpitis 2

1.41

0.63

10.1

9.0

—

Other and unspecified tonsillitis

1.66

0.62

11.5

10.7

—

Symptoms and signs involving the nervous and musculoskeletal systems

102

0.59

0.62

5.8

9.7

—

Transport accidents

1.52

0.61

13.3

8.7

—

Glomerular diseases

1.67

0.61

15.4

9.3

—

Other and unspecified nerve root and plexus disorders, also in other diseases

1.67

0.61

12.8

8.0

—

Covid-19 suspected case

1.67

0.61

6.0

10.8

—

Other menopausal disorders

1.59

0.61

10.3

5.6

—

Sensorineural hearing loss

102

1.37

0.61

7.9

8.8

—

Exclusions for E4_PCOS_CONSORTIUM

1.42

0.61

10.9

7.9

—

Mood [affective] disorders

130

1.32

0.61

9.5

9.2

—

Unstable angina pectoris

1.59

0.61

10.3

8.5

—

Coxibs

1.58

0.61

7.4

10.6

—

Mood disorders

130

1.31

0.61

9.5

9.2

—

Syncope and collapse

1.55

0.60

11.6

8.1

—

COPD, hospital admissions

1.49

0.60

9.4

9.1

—

Other and unspecified dermatitis

1.48

0.60

9.1

9.6

—

Intestinal stricture

1.57

0.60

11.4

9.1

—

Haemorrhoids and perianal venous thrombosis

1.57

0.60

11.1

8.5

—

Achilles tendinitis

0.00

0.60

0.0

9.5

—

Abnormal involuntary movements

0.00

0.60

0.0

11.5

—

Arthrosis

1.37

0.59

9.7

7.5

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

128

1.29

0.59

7.3

9.5

—

Open wound of head

1.47

0.59

12.2

9.2

—

Abnormal spermatozoa

0.00

0.59

0.0

8.1

—

Obstructed labour due to maternal pelvic abnormality

0.00

0.59

0.0

8.9

—

HSIL lesion of the cervix uteri

0.00

0.59

0.0

11.1

—

Dementia in Alzheimer disease

0.00

0.59

0.0

9.8

—

Benign mammary dysplasia

0.00

0.58

0.0

8.5

—

Benign lipomatous neoplasm

1.51

0.58

8.3

9.0

—

Diverticular disease of intestine

1.37

0.58

11.3

8.7

—

Shoulder lesions

1.36

0.58

8.0

7.9

—

5-aminosalicylic acid

1.71

0.57

9.3

9.5

—

Basal cell carcinoma

1.42

0.57

8.6

8.5

—

Bleeding

114

1.34

0.57

11.1

9.2

—

Schizophrenia, schizotypal and delusional disorders

1.48

0.57

3.5

11.0

—

Diaphragmatic hernia

1.48

0.57

12.9

8.3

—

Injury, poisoning and certain other consequences of external causes

1.45

0.57

11.2

8.1

—

Depression

126

1.31

0.56

10.2

9.1

—

Myalgia

1.67

0.56

10.2

8.0

—

Other nutritional deficiencies

104

1.41

0.56

6.1

9.5

—

Haemorrhage from respiratory passages

1.46

0.56

7.3

9.2

—

Schizophrenia or delusion

1.45

0.56

3.5

11.3

—

Injuries to the knee and lower leg

135

1.27

0.56

9.1

—

Unspecified fall

0.56

13.6

9.9

—

Disorders of other endocrine glands

1.50

0.55

7.3

9.2

—

DVT of lower extremities and pulmonary embolism

1.50

0.55

12.5

8.8

—

Fall on same level

132

1.27

0.55

10.1

9.2

—

Allergic conjunctivitis

1.42

0.55

9.4

8.5

—

Dyspnoea

128

1.32

0.54

6.3

9.6

—

Dental caries 2, only avohilmo

117

0.67

0.54

8.1

9.7

—

Injuries to the neck

1.58

0.54

14.0

9.8

—

Ovarian cyst

1.56

0.54

10.2

6.8

—

Menorrhagia

1.46

0.54

8.1

6.0

—

Systemic connective tissue disorders

1.48

0.53

2.6

9.0

—

Kela-code for severe mental illness

1.48

0.53

7.0

11.3

—

Dental caries 2 and operation codes, only avohilmo

0.66

0.53

7.7

8.8

—

Sciatica+with lumbago

1.44

0.53

9.6

8.8

—

Aortic aneurysm

1.55

0.53

9.5

8.9

—

Other anxiety disorders

1.53

0.53

14.9

8.1

—

Hypertensive heart and/or renal disease

1.55

0.53

18.5

9.2

—

Endometriosis

1.45

0.53

7.9

6.8

—

COPD, hospital admissions 1, only main diagnosis

1.45

0.53

12.4

9.2

—

Internal derangement of knee

1.45

0.52

8.4

8.2

—

Basal cell carcinoma, including avohilmo

1.39

0.51

8.6

8.5

—

Polyuria

1.50

0.51

7.8

9.5

—

Falls/tendency to fall

115

1.26

0.51

11.9

8.5

—

Artrosis, including avohilmo

102

1.29

0.50

10.0

8.7

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1.46

0.50

4.2

10.1

—

Unspecified mental disorder

1.49

0.49

7.5

11.2

—

Gonarthrosis, primary, with knee surgery

0.65

0.49

4.7

8.5

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

0.63

0.49

9.0

8.3

—

Calcific aortic valvular stenosis

1.56

0.49

17.0

7.4

—

Calcific aortic valvular stenosis, operated

1.56

0.49

17.0

7.4

—

Operations 2 for CAVS

1.56

0.49

17.0

7.4

—

Calcific aortic valvular stenosis, diagnosis (helper)

1.56

0.49

17.0

7.4

—

Speech therapy

1.56

0.48

12.9

8.2

—

Calcific aortic valvular stenosis, including rheumatic fever

1.52

0.48

17.0

7.6

—

Ulcerative colitis

1.52

0.48

8.3

9.2

—

Polycystic ovarian syndrome, consortium definition

1.36

0.47

8.3

7.6

—

Colonic or urogenital fistula

1.49

0.47

16.4

8.5

—

Other external causes of accidental injury

1.28

0.47

11.0

8.0

—

Acute alcohol intoxication

1.46

0.46

7.3

9.7

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.46

0.46

8.6

9.4

—

Alcohol use disorder, ICD-based

1.43

0.45

6.7

10.6

—

Injuries to the thorax

1.43

0.45

8.1

9.7

—

Carpal tunnel syndrome

1.36

0.44

7.5

8.4

—

Fracture of rib(s), sternum and thoracic spine

1.37

0.44

9.1

9.6

—

Other intervertebral disc disorders

106

1.27

0.43

10.6

9.3

—

Gastrointestinal diseases

1.38

0.43

12.6

8.1

—

Later onset COPD, excluding more controls

1.62

0.43

5.2

7.8

—

Fenamates

1.61

0.43

14.0

8.2

—

Inflammatory bowel disease

1.43

0.42

9.4

9.8

—

Dental pulpitis 3

0.00

0.42

0.0

10.8

—

Intracranial trauma

1.33

0.42

13.0

8.6

—

Endometriosis ASRM stages 3,4

1.56

0.42

9.4

9.7

—

Dental pulpitis 3, only avohilmo

0.00

0.42

0.0

10.8

—

Abrasion of teeth

1.53

0.41

11.8

7.6

—

Carbimazole or st.post thyroidectomy, condition for graves disease

1.52

0.41

7.6

9.2

—

Type 1 diabetes, wide definition, subgroup 1

1.51

0.41

16.2

10.5

—

Otosclerosis

0.00

0.41

0.0

14.1

—

Bitten or struck by other mammals

0.00

0.41

0.0

13.7

—

LSIL lesion of the cervix uteri

0.00

0.41

0.0

10.1

—

Other strabismus

1.51

0.41

7.8

10.3

—

Non-selective monoamine reuptake inhibitors

1.43

0.41

13.2

7.2

—

Normotensive glaucoma

0.00

0.41

0.0

10.9

—

Other peripheral vertigo

0.00

0.41

0.0

12.1

—

Other benign neoplasms of connective and other soft tissue

0.00

0.41

0.0

13.9

—

Persons encountering health services in other circumstances, wide

128

1.22

0.41

9.5

—

Rotator cuff syndrome

1.33

0.41

8.6

7.8

—

Urolithiasis

1.36

0.41

13.4

9.6

—

Dental caries 1 and operation codes

1.26

0.41

10.0

9.8

—

Dental caries, including avohilmo

1.28

0.40

10.3

9.2

—

Dental caries 1

1.28

0.40

10.3

9.2

—

Noninfective enteritis and colitis

1.39

0.40

9.7

—

Pain associated with micturition

0.00

0.40

0.0

10.9

—

Other/unspecified rheumatoid arthritis

0.00

0.40

0.0

10.9

—

Disorders of gallbladder, biliary tract and pancreas

125

1.24

0.39

10.2

9.0

—

Sleep disorders (combined)

142

0.78

0.39

8.1

9.5

—

Preterm labour and delivery

1.43

0.39

9.6

9.9

—

Pleural plaque

0.00

0.39

0.0

8.6

—

Infective dermatitis

0.00

0.39

0.0

10.1

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

0.39

0.0

10.5

—

Glaucoma suspect

1.36

0.38

9.0

8.0

—

Use of pramipexole

1.39

0.38

10.0

7.3

—

Type 1 diabetes, wide definition

1.39

0.38

16.2

11.0

—

Cardiodefibrillation

1.34

0.38

11.1

9.0

—

Chronic diseases of tonsils and adenoids

0.74

0.38

9.6

9.3

—

Senile cataract

1.29

0.37

10.8

8.3

—

Cervicalgia

1.35

0.37

18.4

8.5

—

Lumbar disc prolapse

1.28

0.36

11.4

9.2

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.32

0.36

10.1

8.3

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1.36

0.36

6.7

10.8

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

0.63

0.35

4.8

8.6

—

Conduction disorders

1.42

0.35

12.2

7.3

—

Benign neoplasm: Colon, unspecified

1.43

0.35

3.3

8.7

—

Sequelae of injuries, of poisoning and of other consequences of external causes

1.40

0.35

20.0

9.3

—

Accidents

1.23

0.34

10.7

8.0

—

Papulosquamous disorders

1.37

0.34

7.2

8.6

—

Malignant neoplasm of skin

1.28

0.34

10.0

8.4

—

Primary coxarthrosis, bilateral

1.33

0.33

5.2

8.2

—

Other disorders of skin and subcutaneous tissue

116

1.26

0.33

9.6

8.9

—

Soft tissue disorders related to use, overuse and pressure

1.30

0.33

15.7

7.6

—

Disorders of conjunctiva

129

1.23

0.33

12.2

8.6

—

Other symptoms and signs involving cognitive functions and awareness

1.36

0.33

7.9

9.1

—

Alcohol use disorder, Swedish definition

1.30

0.33

8.2

10.5

—

Other disorders of urethra and urinary system

1.26

0.32

11.1

7.7

—

Mental and behavioural disorders due to alcohol

1.31

0.32

6.3

10.5

—

Injuries to the head

142

1.19

0.32

11.7

8.7

—

Symptoms and signs involving the circulatory and respiratory systems

100

1.20

0.31

9.1

9.7

—

Other arthrosis

0.72

0.31

7.3

7.0

—

Reimbursement for rheumatic diseases

101

1.28

0.31

5.6

9.5

—

Other diseases of the digestive system

1.35

0.31

10.1

8.6

—

Diseases of the musculoskeletal system and connective tissue

1.30

0.31

14.5

8.0

—

Factors influencing health status and contact with health services

1.30

0.31

9.1

9.6

—

Malignant neoplasm of breast, HER-positive

1.33

0.31

11.9

7.6

—

GI-bleeding

1.30

0.30

10.1

8.5

—

Hernia of abdominal wall

1.33

0.30

5.5

9.4

—

Other maternal disorders predominantly related to pregnancy

0.74

0.30

11.6

8.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.27

0.30

10.6

9.7

—

Dermatitis

111

1.26

0.30

9.4

—

Diseases of the digestive system

1.33

0.29

13.0

8.4

—

Asthma/COPD (KELA code 203)

123

1.20

0.29

5.7

10.1

—

Fitting and adjustment of other devices

1.25

0.29

10.9

8.3

—

Pulmonary heart disease, diseases of pulmonary circulation

1.25

0.29

4.3

8.5

—

Transient ischemic attack

1.29

0.29

9.4

7.9

—

Selective serotonin reuptake inhibitors

111

1.19

0.29

11.1

8.7

—

1.32

0.28

6.3

10.7

—

Angina pectoris

1.26

0.28

12.3

8.1

—

Concussion

1.28

0.28

12.0

8.5

—

Temporomandibular joint disorders, including avohilmo

1.27

0.27

12.0

8.2

—

Fracture of shoulder and upper arm

1.25

0.27

8.5

8.7

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.68

0.27

7.2

9.5

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

127

1.18

0.26

11.8

8.6

—

Disorders of lens

1.22

0.26

10.8

8.5

—

101

1.24

0.26

7.6

10.8

—

Pregnancy hypertension

0.70

0.26

4.8

9.0

—

0.70

0.26

13.0

8.3

—

Rheumatoid arthritis, including avohilmo

0.69

0.26

4.0

8.4

—

External causes of morbidity and mortality

1.22

0.25

10.9

7.8

—

Malignant neoplasm of prostate

1.21

0.25

9.6

9.8

—

Single spontaneous delivery

1.20

0.25

11.7

6.7

—

Delivery

1.19

0.25

12.2

6.7

—

Dental caries 2

117

0.81

0.25

6.9

9.8

—

Dementia, including avohilmo

0.73

0.24

8.5

8.4

—

Hernia

121

1.18

0.24

9.4

9.6

—

Diseases of appendix

135

0.81

0.24

9.7

9.6

—

Open wound of wrist and hand

1.17

0.24

11.2

11.3

—

Other retinal disorders

1.22

0.24

11.1

8.8

—

Disorders of breast

0.73

0.24

6.7

8.1

—

Appendicitis, broad definition

135

0.81

0.24

9.7

9.6

—

Dental operations, only avohilmo

1.20

0.23

11.7

9.5

—

Malignant neoplasm of bronchus and lung

1.34

0.23

2.4

10.0

—

Nasal polyp

1.32

0.23

1.0

9.2

—

Fracture of foot, except ankle

1.32

0.23

12.2

9.2

—

Presence of other devices

1.32

0.23

10.6

7.6

—

Disorders of refraction and accommodation

1.31

0.23

13.6

9.4

—

Cerebrovascular diseases

102

1.19

0.23

11.0

8.7

—

Cellulitis

1.28

0.23

15.2

9.4

—

Peritonsillar abscess

1.28

0.23

13.4

9.6

—

Dysphagia

1.28

0.23

6.6

6.8

—

Irritable bowel syndrome

1.28

0.23

14.0

8.9

—

Other noninfective gastroenteritis and colitis

1.28

0.23

6.8

9.2

—

Other cataract

0.75

0.22

9.6

7.6

—

Cholecystectomy

120

0.81

0.22

9.7

8.2

—

Fibroblastic disorders

1.25

0.22

13.0

8.4

—

IBD patients in KELA-register

1.25

0.22

10.2

10.0

—

Dentofacial anomalies [including malocclusion]

1.24

0.22

12.0

8.1

—

Injuries to the elbow and forearm

113

1.20

0.22

8.2

9.8

—

Inflammatory bowel disease, strict (require KELA)

1.22

0.22

10.2

10.3

—

Dental caries 2 and operation codes

116

0.82

0.21

6.9

9.9

—

L02BX Other hormone antagonists and related agents

0.00

0.21

0.0

9.0

—

Other secondary gonarthrosis

0.00

0.21

0.0

14.6

—

Oral lichen ruber planus, including avohilmo

0.00

0.21

0.0

13.2

—

Thyrotoxicosis with toxic multinodular goitre

0.00

0.21

0.0

13.7

—

Disorders of calcium metabolism

0.00

0.21

0.0

12.0

—

Varicose veins of other sites

0.00

0.21

0.0

12.3

—

Ascites

0.00

0.21

0.0

9.3

—

Tubulo-interstitial nephritis, not specified as acute or chronic

0.00

0.21

0.0

12.9

—

0.00

0.21

0.0

8.7

—

Cardiomyopathy, other and unspecified

0.00

0.21

0.0

8.5

—

Haemangioma, any site

0.00

0.21

0.0

13.4

—

Allergic urticaria

0.00

0.21

0.0

12.6

—

Demyelinating diseases of the central nervous system

0.00

0.21

0.0

12.7

—

Scoliosis

0.00

0.21

0.0

13.2

—

Carcinoma in situ of cervix uteri

0.00

0.21

0.0

10.1

—

Sequelae of injuries of lower limb

0.00

0.21

0.0

12.7

—

Pilonidal cyst

0.00

0.21

0.0

10.8

—

Eating disorders

0.00

0.21

0.0

12.2

—

Malignant neoplasm of respiratory system and intrathoracic organs

1.18

0.21

2.4

9.5

—

Bronchiectasis

0.00

0.21

0.0

12.6

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

0.00

0.21

0.0

16.1

—

Unknown and unspecified causes of morbidity

0.00

0.21

0.0

8.4

—

Sicca syndrome [Sjögren]

0.00

0.21

0.0

12.4

—

Haemangioma and lymphangioma, any site

0.00

0.21

0.0

14.1

—

Osteopathies and chondropathies

0.79

0.21

10.0

8.9

—

Tinnitus

1.16

0.21

9.0

10.1

—

Impingement syndrome of shoulder

1.16

0.21

5.0

8.8

—

Paralytic ileus and intestinal obstruction

1.16

0.21

12.8

8.1

—

Presence of cardiac and vascular implants and grafts

1.24

0.21

13.2

8.6

—

Vasomotor rhinitis (mode)

0.00

0.21

0.0

13.5

—

Spirochaetal infections, other/unspecified

0.00

0.21

0.0

12.6

—

Disorders of mineral metabolism

0.00

0.21

0.0

12.6

—

Cerebral aneurysm, nonruptured

0.00

0.21

0.0

11.8

—

Other appendicitis

0.00

0.21

0.0

14.2

—

Other/unspecified enthesopathies, not elsewhere classified

0.00

0.21

0.0

9.0

—

Sequelae of injuries of upper limb

0.00

0.21

0.0

13.9

—

Infections of genitourinary tract in pregnancy

0.00

0.21

0.0

11.8

—

Personal history of other diseases and conditions

0.00

0.21

0.0

13.5

—

Diseases of the skin and subcutaneous tissue

105

1.15

0.20

11.9

9.1

—

Disorders of choroid and retina

112

1.17

0.20

10.8

9.2

—

Carcinoma in situ of skin

0.00

0.20

0.0

10.4

—

Use of antiglaucoma preparations and miotics

0.00

0.20

0.0

9.0

—

Other and unspecified glaucoma

0.00

0.20

0.0

9.0

—

Other noninflammatory disorders of vulva and perineum

0.00

0.20

0.0

8.9

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.25

0.20

7.2

11.0

—

Inflammatory diseases of female pelvic organs

1.22

0.20

6.0

8.1

—

Deforming dorsopathies

1.22

0.20

10.3

9.0

—

Later onset COPD

1.21

0.20

6.8

9.3

—

Care involving use of rehabilitation procedures

103

1.20

0.19

11.1

9.0

—

Other disorders of fluid, electrolyte and acid-base balance

1.16

0.19

13.8

9.1

—

Sulfasalazine

1.15

0.19

5.0

9.5

—

Hypothyroidism, strict autoimmune

0.84

0.18

8.6

9.1

—

Varicose veins

0.82

0.18

10.6

8.1

—

Calculus of kidney and ureter

1.21

0.18

13.3

9.5

—

Medicines for HER+ breast cancer

1.20

0.18

11.9

7.9

—

Diseases of external ear

1.19

0.18

7.3

8.7

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

112

0.85

0.18

8.9

8.7

—

Dental caries 3 and operation codes, only avohilmo

1.13

0.18

13.3

10.1

—

Retinal detachments and breaks

1.13

0.17

4.9

8.8

—

Leiomyoma of uterus

1.19

0.17

11.7

7.0

—

Unspecified haematuria

1.22

0.17

8.3

9.5

—

Sequelae of cerebrovascular disease

1.12

0.17

7.4

8.3

—

Other arrhythmias

1.18

0.17

12.6

8.4

—

Actinic keratosis

0.74

0.17

13.0

8.0

—

Skin changes due to chronic exposure to nonionizing radiation

0.74

0.17

13.0

8.0

—

Excessive, frequent and irregular menstruation

1.14

0.16

11.6

6.5

—

Noninflammatory disorders of female genital tract

0.77

0.16

13.8

6.5

—

Other/unspecified dorsalgia

1.15

0.16

6.9

8.7

—

Hyperlipidaemia, other/unspecified

1.15

0.16

6.4

9.7

—

Dental caries 1, only avohilmo

1.14

0.16

9.6

9.5

—

Conjunctivitis

121

1.15

0.16

11.6

8.5

—

Gonarthrosis [arthrosis of knee](FG)

1.15

0.16

11.2

8.3

—

malignant neoplasm of male genital organs

1.17

0.15

9.6

10.0

—

Other functional intestinal disorders

0.79

0.15

3.7

8.9

—

Malignant neoplasm of breast, HER2-negative

1.16

0.15

12.1

7.4

—

Disorders of synovium and tendon

1.19

0.15

9.3

8.0

—

Malignant neoplasm of breast

1.14

0.15

12.1

7.4

—

Tonsillectomy and adenotomy

0.81

0.14

16.8

8.9

—

Triptan medication for migraine, min. 3 purchases

0.83

0.14

9.1

—

Meniscus derangement

0.79

0.14

13.0

7.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1.17

0.14

12.2

8.3

—

Diseases of inner ear

0.83

0.13

5.8

8.5

—

Injuries to the ankle and foot

111

1.15

0.13

12.2

9.6

—

Complications of labour and delivery

0.84

0.13

9.5

7.8

—

Presence of other functional implants

0.85

0.12

7.8

—

Acute appendicitis

130

0.87

0.12

9.7

—

Migraine

1.18

0.12

11.3

8.4

—

Disorders of the thyroid gland

124

1.11

0.12

8.7

9.0

—

Degeneration of macula and posterior pole

1.18

0.12

8.5

8.2

—

Congenital malformations, deformations and chromosomal abnormalities

100

1.15

0.11

9.4

9.6

—

Benign neoplasm: Colon

1.16

0.11

11.0

8.7

—

Intracranial injury

1.16

0.11

12.5

9.2

—

Dental caries 3 and operation codes

1.10

0.10

10.3

9.8

—

Ventral hernia

1.14

0.10

5.8

8.6

—

Sequelae of external causes of morbidity and mortality

1.14

0.10

10.2

8.6

—

L02BG Aromatase inhibitors

1.14

0.10

9.0

8.2

—

Haemorrhage in early pregnancy

1.13

0.10

8.8

8.4

—

Type 1 diabetes

1.13

0.10

16.2

10.5

—

Lyme disease

1.11

0.09

16.2

8.2

—

Other spirochaetal diseases

1.09

0.09

16.2

8.5

—

Umbilical hernia

1.09

0.09

5.2

9.3

—

1.05

0.09

7.4

8.5

—

Dental caries 1 and operation codes, only avohilmo

1.12

0.09

14.2

10.3

—

Symptoms and signs involving the urinary system

112

1.10

0.09

8.6

9.3

—

Female genital prolapse

1.05

0.08

13.2

6.2

—

Chronic rhinitis, nasopharyngitis and pharyngitis

1.05

0.08

3.7

9.7

—

Delivery, wide proxy

1.13

0.08

8.7

5.8

—

Urticaria and erythema

0.83

0.08

9.4

9.3

—

Vasomotor and allergic rhinitis

0.79

0.08

11.6

9.6

—

Other benign neoplasms of skin

1.09

0.08

11.7

8.6

—

Injury of muscle and tendon at shoulder and upper arm level

1.08

0.08

7.1

9.4

—

Dementia

0.83

0.08

8.5

8.2

—

Cervical disc disorders

1.03

0.07

10.0

8.8

—

Extrapyramidal and movement disorders

1.03

0.07

15.7

8.9

—

Malignant neoplasm of digestive organs

0.86

0.07

3.3

8.8

—

Appendectomy

118

0.90

0.07

9.3

9.4

—

Fracture of forearm

1.12

0.07

10.4

9.2

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

0.85

0.07

9.0

8.5

—

Other disorders of eyelid

1.02

0.07

8.1

—

Disorders of skin appendages

0.86

0.07

11.9

9.8

—

Dental caries 3, only avohilmo

1.08

0.06

9.7

9.4

—

Glaucoma

0.90

0.06

9.6

8.3

—

Dental caries 3

1.08

0.06

10.6

9.1

—

Acute appendicitis, no complications

105

0.85

0.06

10.2

9.9

—

Hypothyroidism, other/unspecified

117

1.07

0.06

7.5

8.7

—

Primary gonarthrosis, bilateral

1.11

0.05

4.8

8.8

—

Gonarthrosis

1.09

0.05

9.6

7.3

—

101

1.09

0.05

6.3

10.8

—

Other diseases of urinary system

112

1.05

0.04

13.8

8.2

—

Inguinal hernia

1.08

0.03

9.9

10.4

—

Medical abortion

0.92

0.03

8.3

8.1

—

Neurological diseases

1.05

0.02

11.8

9.2

—

Injuries to the wrist and hand

144

0.96

0.02

8.3

9.3

—

Gonarthrosis,primary

118

0.96

0.01

9.1

8.6

—

Episodal and paroxysmal disorders

127

0.97

0.01

11.6

9.2

—

Other diseases of upper respiratory tract

116

1.03

0.01

10.1

9.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

121

1.04

0.01

7.5

9.0

—

Fracture of lower leg, including ankle

1.06

0.00

5.4

9.3

—

Atopic dermatitis

1.04

0.00

4.4

10.2

—

Injuries to the shoulder and upper arm

138

0.97

0.00

9.6

—

Cholelithiasis

117

1.02

0.00

9.5

8.7

—

Cholelithiasis, broad definition with cholecystitis

119

0.98

0.00

10.2

8.8

—

Constipation

120

1.01

0.00

8.4

9.4

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1.05

0.00

9.9

—

Infections of the skin and subcutaneous tissue

1.01

0.00

14.0

9.8

—

Pregnancy with abortive outcome

1.05

0.00

10.4

7.9

—

Barrett oesophagus

0.00

0.0

10.5

—

Convalescence

0.00

0.0

14.0

—

Pedestrian injured in transport accident

0.00

0.0

11.6

—

Caught, crushed, jammed or pinched in or between objects

0.00

0.0

15.8

—

Female infertility, associated with anovulation

0.00

0.0

11.4

—

Sub-endpoint used in defining T1D endpoints

0.89

0.00

16.2

10.0

—

0.00

0.0

5.3

—

Unspecified jaundice

0.00

0.0

7.7

—

Impotence

0.00

0.0

10.4

—

Suppurative and necrotic conditions of lower respiratory tract

0.00

0.0

12.0

—

Use of ropinirole

0.00

0.0

10.2

—

Abnormal findings on antenatal screening of mother

0.00

0.0

12.3

—

Inflammatory disorders of breast

0.00

0.0

12.4

—

Alcohol dependence

1.00

0.00

3.2

11.0

—

Autoimmune hyperthyroidism

0.00

0.0

14.1

—

Other deformities of toe(s)

0.00

0.0

10.0

—

Other enthesopathies

0.89

0.00

11.2

8.4

—

KRA_PSY_EATING, excluding more controls

0.00

0.0

9.2

—

Other aneurysm

0.00

0.0

10.8

—

Dermatographic urticaria

0.00

0.0

14.1

—

Ingrowing nail

0.00

0.0

10.6

—

Prepatellar bursitis

0.00

0.0

10.4

—

Other specified/unspecified systemic involvement of connective tissue

0.00

0.0

15.1

—

Presbyopia

0.00

0.0

14.6

—

Bullous disorders

0.00

0.0

12.1

—

Labour and delivery complicated by umbilical cord complications

0.00

0.0

10.4

—

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Melanocytic naevi, other sites/unspecified

0.00

0.0

14.2

—

Nonspecific lymphadenitis

0.00

0.0

15.2

—

Scleritis and episcleritis

0.00

0.0

13.0

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

0.00

0.0

13.7

—

Eating disorder

0.00

0.0

13.6

—

Corns and callosities

0.00

0.0

13.9

—

Vitamin deficiency, wide

0.00

0.0

11.5

—

Pacemaker

0.92

0.00

14.6

8.6

—

Use of biperiden

0.00

0.0

12.4

—

Additional codes for the location of defect, injury or illness

0.00

0.0

13.8

—

Obesity related asthma

0.85

0.00

2.4

9.9

—

Polycystic ovarian syndrome

0.00

0.0

11.4

—

Rheumatoid arthritis

0.91

0.00

4.0

6.3

—

Vascular syndromes of brain in cerebrovascular disorders

0.00

0.0

10.0

—

Glaucoma secondary to other eye disorders

0.00

0.0

10.0

—

Hypermetropia

0.00

0.0

15.0

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

0.00

0.0

7.9

—

Maternal care for cervical incompetence

0.00

0.0

8.4

—

Heterophoria

0.00

0.0

15.3

—

Abnormal blood-pressure reading, without diagnosis

0.00

0.0

14.2

—

Nail disorders

0.00

0.0

15.2

—

Mouth breathing

0.88

0.00

4.5

10.1

—

Other viral hepatitis

0.00

0.0

11.0

—

Vulvovaginal ulceration/inflammation in other diseases

0.00

0.0

11.1

—

Vitamin deficiency

0.00

0.0

11.5

—

Noise effects on inner ear

0.00

0.0

12.9

—

Asthma and opportunity respiratory infection

0.00

0.0

11.7

—

Herpesviral keratitis and keratoconjunctivitis

0.00

0.0

13.5

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1.00

0.00

11.5

9.3

—

Keratitis

0.95

0.00

8.0

9.7

—

Symptoms and signs involving speech and voice

0.93

0.00

9.6

7.6

—

Other osteochondropathies

0.00

0.0

11.6

—

Other benign neoplasms of connective and other soft tissue

0.00

0.0

1.0

—

Non-small cell lung cancer, squamous, helper endpoint

0.00

0.0

6.9

—

Use of selegiline

0.00

0.0

10.4

—

Polyp of the female genital tract

0.88

0.00

5.8

6.2

—

Disorders of lacrimal system

0.97

0.00

14.1

8.7

—

Carcinoma in situ of cervix uteri

0.00

0.0

2.0

—

Trigeminal neuralgia

0.00

0.0

10.2

—

Other disorders of lacrimal gland

0.85

0.00

16.6

8.5

—

Other and unspecified disorders of skin and subcutaneous tissue

0.00

0.0

13.4

—

Cerebral cysts

0.00

0.0

8.2

—

Residual foreign body in soft tissue

0.00

0.0

11.8

—

Pulmonary heart disease

0.93

0.00

5.6

8.3

—

Organic, including symptomatic, mental disorders

0.90

0.00

7.3

8.5

—

Primary angle-closure glaucoma

0.00

0.0

12.1

—

Diffuse brain injury

0.00

0.0

6.7

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

0.00

0.0

1.0

—

Secondary parkinsonism, excluding more controls

0.00

0.0

11.4

—

Oral lichen ruber planus wide, hypothyreosis or thyroxin

0.00

0.0

13.4

—

Benign neoplasm: Choroid

0.00

0.0

13.0

—

Traumatic amputation of wrist and hand

0.00

0.0

10.0

—

Unspecific neurodegenerative disorder

0.92

0.00

8.5

7.8

—

Polycystic ovarian syndrome, broad definition

0.00

0.0

14.9

—

Other follicular disorders

0.00

0.0

12.9

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

0.00

0.0

11.3

—

Other general symptoms and signs

0.00

0.0

9.8

—

Crohn's disease of large intestine

0.00

0.0

12.2

—

Diffuse large B-cell lymphoma

0.00

0.0

10.0

—

Antepartum haemorrhage, not elsewhere classified

0.00

0.0

10.1

—

Malignant neoplasm of stomach

0.00

0.0

10.2

—

Sulfonylureas

0.94

0.00

6.3

9.0

—

Asthma mixed form (mode), excluding more controls

0.00

0.0

7.3

—

Unspecified abortion

0.00

0.0

9.4

—

Other specified/unspecified inflammatory spondylopathies

0.00

0.0

12.2

—

Carcinoma in situ of skin

0.00

0.0

1.0

—

Traumatic subarachnoid haemorrhage

0.00

0.0

5.4

—

Retention of urine

0.87

0.00

11.0

9.6

—

Viral infections of the central nervous system

0.00

0.0

12.3

—

Procreative management

0.88

0.00

13.2

10.1

—

Episcleritis

0.00

0.0

13.0

—

Other puerperal infections

0.00

0.0

3.8

—

Dislocation, sprain and strain of joints and ligaments of elbow

0.00

0.0

16.3

—

Anorexia (incl.atypical)

0.00

0.0

10.7

—

Lichen simplex chronicus and prurigo

0.00

0.0

14.0

—

Obesity due to excess calories

0.93

0.00

6.6

9.3

—

Sequelae of other external causes

0.00

0.0

13.6

—

Non-small cell lung cancer, squamous

0.00

0.0

6.9

—

Nonischemic cardiomyopathy

0.00

0.0

8.1

—

Disorders of vestibular function (Vertigo)

0.95

0.00

5.8

8.7

—

therapeutic use

0.00

0.0

11.5

—

Asthma mixed form (mode)

0.00

0.0

6.4

—

Other otitis externa (chronic)

0.00

0.0

14.6

—

Visual impairment including blindness (binocular or monocular)

0.00

0.0

11.7

—

Other headache syndromes

0.99

0.00

13.4

8.6

—

Oligomenorrhoea

0.00

0.0

11.5

—

Medial epicondylitis

0.00

0.0

10.0

—

Other disorders of veins

0.94

0.00

13.0

7.5

—

Vascular dementia

0.00

0.0

9.1

—

Alzheimer’s disease (Atypical or mixed)

0.00

0.0

9.0

—

Alzheimer’s disease (Early onset)

0.00

0.0

10.0

—

MS-disease / Multiple Sclerosis

0.00

0.0

10.8

—

Respiratory tuberculosis, not confirmed

0.00

0.0

7.2

—

Disorders of sclera, cornea, iris and ciliary body

0.92

0.00

8.9

10.0

—

Other eating disorders

0.00

0.0

10.6

—

Epilepsy

1.01

0.00

10.7

9.1

—

Contact with other sharp object(s)

0.00

0.0

13.2

—

Follow-up care involving plastic surgery

0.00

0.0

14.6

—

Persons with potential health hazards related to communicable diseases

0.87

0.00

10.8

9.9

—

Infective bursitis

0.00

0.0

15.8

—

Congenital malformations of eye, ear, face and neck

0.00

0.0

10.3

—

Dementia in other diseases classified elsewhere

0.00

0.0

10.4

—

Inflammatory disease of cervix uteri

0.00

0.0

13.1

—

Pulmonary embolism

0.94

0.00

5.6

8.5

—

Normal-pressure hydrocephalus

0.00

-0.00

0.0

8.1

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS